FRAMINGHAM, Mass., April 05, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...
This guide breaks down what separates enterprise-grade HME/DME billing platforms from glorified spreadsheets, which features actually move the needle on reimbursement rates, and how to evaluate ...
FRAMINGHAM, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical ...
The July 1 quarterly HCPCS Level II update includes several drug/biological code changes, according to an AAPC release. Effective July 1, the HCPCS Level II code J7184 will be replaced with Q2041 ...
CMS has announced it will begin reimbursing for four new Q codes effective for claims with dates of service on or after July 1. The new codes have an MPFSDB status indicator of E. CMS also announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results